絞り込み

16406

広告

925件中 1件~20件表示    検索結果をPubMedで見る PubMedで見る

Comparison of Oral Anticoagulants for Stroke Prevention in Nonvalvular Atrial Fibrillation: A Multicriteria Decision Analysis.

Edoxaban for the Treatment of Cancer-Associated Venous Thromboembolism.

Update on the use of direct oral anticoagulants for the prevention and treatment of thromboembolism.

Edoxaban for the management of elderly Japanese patients with atrial fibrillation ineligible for standard oral anticoagulant therapies: Rationale and design of the ELDERCARE-AF study.

Outpatient Management in Patients with Venous Thromboembolism with Edoxaban: A Post Hoc Analysis of the Hokusai-VTE Study.

[Laboratory aspects of novel oral anticoagulant treatment].

Laboratory Testing In Patients Treated With Direct Oral Anticoagulants: A Practical Guide For Clinicians.

Comparison of major bleeding risk in patients with non-valvular atrial fibrillation receiving direct oral anticoagulants in the real-world setting: a network meta-analysis.

Oral anticoagulants for prevention of stroke in atrial fibrillation: systematic review, network meta-analysis, and cost effectiveness analysis.

Real-world Data and Recommended Dosage of Non-vitamin K Oral Anticoagulants for Korean Patients.

Relation of Stroke and Bleeding Risk Profiles to Efficacy and Safety of Edoxaban for Cardioversion of Atrial Fibrillation (from the EdoxabaN versus warfarin in subjectS UndeRgoing cardiovErsion of Atrial Fibrillation [ENSURE-AF] Study).

Use of direct oral anticoagulants in the first year after market entry of edoxaban: A Danish nationwide drug utilization study.

Tranexamic Acid Failed to Reverse the Anticoagulant Effect and Bleeding by an Oral Direct Factor Xa Inhibitor Edoxaban.

The relationship of renal function to outcome: A post hoc analysis from the EdoxabaN versus warfarin in subjectS UndeRgoing cardiovErsion of Atrial Fibrillation (ENSURE-AF) study.

Direct oral anticoagulants use in elderly patients with non valvular atrial fibrillation: state of evidence.

[Low or reduced? Semantics of the doses of new oral anticoagulants].

Direct oral anticoagulants versus warfarin for preventing stroke and systemic embolic events among atrial fibrillation patients with chronic kidney disease.

[Recent and upcoming randomized trials for left atrial appendage occlusion : Need for a definite assessment of the situation].

Edoxaban improves acute venous thromboembolism while preserving protein C and protein S levels.

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
Sort by
※並べ替えは表示に時間がかかります